Editor’s Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from November 9-15, 2024.
Don received a double-lung, kidney and liver transplant after a condition called Alpha-1 damaged his vital organs.
Nature – Researchers can craft their own polished, professional figures and images with the help of these tools and design principles.
LMNT co-founder and part-owner Robb Wolf has some explaining to do about the recent discovery that LMNT electrolytes contain 100x more maltodextrin than clai…
Disinformation is the new normal with far reaching implications for society, including population health. Martin McKee and colleagues outline the challenges and propose a way…
Audio Interview from the New England Journal of Medicine — NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
Automated social media profiles are a powerful tool for spreading propaganda. They often feature AI-generated profile pictures. Researchers are currently looking into ways of identifying…
The SPIRIT-iNeurostim extension will help to promote increased transparency, clarity, and completeness of reporting trial protocols evaluating implantable neurostimulation devices. It will assist journal editors,…
Background Endometriosis, affecting 10% of women in their reproductive years, remains poorly understood. Both individual and environmental unexplained factors are implicated in this heterogenous condition.…
WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disord
This editorial describes the science behind a study linking a severe neurodevelopmental disorder with deletions in a gene (CHASERR) that encodes a long noncoding RNA.
